In the current issue of Health Affairs, David Wamble and colleagues published a new study - What’s Been The Bang For The Buck? Cost-Effectiveness Of Health Care Spending Across Selected Conditions In The US [1]. In it, they examined disease-level cost-effectiveness ratios, analyzing changes over time in medical intervention spending and the associated changes in health outcomes of patients with seven different diagnoses.